NVLab - Company finances
|
EUR
|
2020
From: 2020-09-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 2,325 | 49,081 | 88,398 | 104,624 | 129,057 | 156,675 |
| Profit before tax | 1,057 | 19,279 | 13,548 | 16,116 | 4,197 | 19,207 |
| Net profit | 1,004 | 18,315 | 12,867 | 15,277 | 3,968 | 18,010 |
| Equity | 1,004 | 19,319 | 32,186 | 47,463 | 45,531 | 66,634 |
| Liabilities | 3,102 | 1,084 | 18,227 | 4,971 | 22,899 | 18,569 |
| Non-current assets | 0 | 481 | 26,027 | 2,403 | 36,055 | 31,137 |
| Current assets | 4,106 | 19,922 | 24,386 | 50,031 | 32,375 | 54,066 |
| Total assets | 4,106 | 20,403 | 50,413 | 52,434 | 68,430 | 85,203 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 707 | 1,011 | 412 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +2011.0% | +80.1% | +18.4% | +23.4% | +21.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.5% | 89.8% | 25.5% | 29.1% | 5.8% | 21.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 94.8% | 40.0% | 32.2% | 8.7% | 27.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 43.2% | 37.3% | 14.6% | 14.6% | 3.1% | 11.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 45.5% | 39.3% | 15.3% | 15.4% | 3.3% | 12.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.1 | 0.1 | 0.6 | 0.1 | 0.5 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
NVLab - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-03 | 2026-02-28 | 80.48 |
| 2025-09-02 | 2025-09-30 | 72.45 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-03-01 | 2025-03-31 | 72.45 |
| 2024-07-02 | 2024-07-31 | 129.00 |
| 2024-06-03 | 2024-07-01 | 64.50 |
| 2023-07-03 | 2023-07-31 | 57.71 |
| 2022-04-01 | 2022-04-30 | 40.38 |
NVLab - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company NVLab is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-18 | 2026-09-02 | 0.64 |
| 2026-03-02 | 2026-03-02 | 24.11 |
| 2026-02-21 | 2026-03-01 | 24.0 |
| 2025-07-07 | 2025-08-18 | 0.08 |
| 2025-07-03 | 2025-07-06 | 0.56 |
| 2025-07-01 | 2025-07-02 | 163.56 |
| 2025-06-19 | 2025-06-30 | 163.0 |
| 2025-04-28 | 2025-05-08 | 1.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
NVLab, MB (code 305616700) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €156.7K and net profit of €18.0K, compared with €129.1K of revenue and €4.0K of net profit in 2024. Revenue therefore continued its upward trend, rising from €104.6K in 2023 to €129.1K in 2024 and €156.7K in 2025. Profitability was more volatile: net profit was €15.3K in 2023, declined in 2024, and then recovered strongly in 2025. The 2025 profit margin was 11.5%. Balance sheet strength remained solid, with total assets of €85.2K, equity of €66.6K and liabilities of €18.6K at year-end 2025. The equity ratio stood at 78.2%, debt-to-equity at 0.28, asset turnover at 1.84x, ROE at 27.0% and ROA at 21.1%.